Endovenous laser ablation (EVLA) vs foam sclerotherapy
Technical success · people with GSV incompetence
Endovenous laser ablation (EVLA) showed no clear difference in technical success (< 5 years) compared with ultrasound‐guided foam sclerotherapy (UGFS) (low certainty).
2 findings from 1 review
- OR 6.13 [0.98, 38.27]3 studies · 588 participantsLow
- OR 6.47 [2.6, 16.1]3 studies · 534 participantsLow